Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With CisplatinJosé Baselga, John Mendelsohn, Gabriella D’Andrea et al.|Journal of Clinical Oncology|2000Cited by 746
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastasesAnna-Maria Lazaratos, Matthew Dankner, Sarah M. Maritan et al.|The Breast|2023Cited by 25
A systematic review and meta-analysis of intrathecal versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.Anna-Maria Lazaratos, Matthew Dankner, Sarah M. Maritan et al.|Journal of Clinical Oncology|2023Cited by 0